/https://media.redcircle.com/images/2025/4/9/18/2d1389e6-dc59-45fb-ab99-b5980d168af5_2044893-1568815755423-9188f1eb48545.jpg)
Run the List
Walker Redd, Emily Gutowski, Navin Kumar, Joyce Zhou, Blake Smith
MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease)
JUN 15, 202628 MIN
/https://media.redcircle.com/images/2025/4/9/18/2d1389e6-dc59-45fb-ab99-b5980d168af5_2044893-1568815755423-9188f1eb48545.jpg)
Description
Dr. Sam Sanders, internist at Bellevue Hospital in NYC, takes us through a case-based review of metabolic dysfunction–associated steatotic liver disease (MASLD), an increasingly common condition. We cover updated terminology, risk stratification using FIB-4 scoring and FibroScans, indications for hepatology referral, and new management strategies to prevent fibrosis progression and cirrhosis.
Advertising Inquiries: https://redcircle.com/brands

